BIOPHARMA
By
U.S. FDA Awards National Priority Review Vouchers to Merck for Cholesterol and Cancer Drug Candidates
United States — The U.S. Food and Drug Administration (FDA) has awarded Commissioner’s National Priority Review Vouchers to…
Pfizer Provides 2026 Financial Guidance and Updates 2025 Revenue Outlook
New York, NY – Pfizer Inc. (NYSE: PFE) today announced its financial guidance for the full year 2026…
Pfizer Celebrates Innovation with 2025 AI Festival
Global – Pfizer hosted its second annual AI Festival Week, bringing together colleagues worldwide to explore the transformative…
Eli Lilly Announces $6 Billion Pharmaceutical Manufacturing Campus in Huntsville, Alabama
Huntsville, AL – Eli Lilly and Company today announced plans to construct a $6 billion pharmaceutical manufacturing campus…
Will AI-Powered Prior Authorization Change How Medicare Care Is Delivered?
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain medical services beginning…
Did 2025 Expose the Breaking Point of America’s Health Care System?
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in the U.S. health…
